Dalfampridine in the treatment of multiple sclerosis: a meta-analysis of randomised controlled trials

Abstract Background Multiple sclerosis (MS) is a chronic illness involving the central nervous system (CNS) that is characterised by inflammation, demyelination, and degenerative changes. Dalfampridine is one of the available treatments for MS symptoms and comorbidities. This meta-analysis aimed to...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Enyao Zhang, Xin Tian, Ruoming Li, Chaoyang Chen, Min Li, Lingyun Ma, Ran Wei, Ying Zhou, Yimin Cui
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2021-02-01
coleção:	Orphanet Journal of Rare Diseases
Assuntos:	Multiple sclerosis Dalfampridine Meta-analysis
Acesso em linha:	https://doi.org/10.1186/s13023-021-01694-8
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!